Cargando…

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma

LncRNA SET-binding factor 2 (SBF2) antisense RNA1 (SBF2-AS1) has been proven to play an oncogenic role in various types of tumors, but the prognostic role of SBF2-AS1 in tumors, especially in diffuse lower-grade glioma (LGG), is still unclear. Here, we aimed to investigate the prognostic value of SB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qiang, Liu, Xiao-Jun, Li, Yang, Ying, Xiao-Wei, Chen, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226362/ https://www.ncbi.nlm.nih.gov/pubmed/34159865 http://dx.doi.org/10.1177/15330338211011966

Ejemplares similares

The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis
por: Wang, Jie, et al.
Publicado: (2021)

Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
por: Lu, Qian, et al.
Publicado: (2021)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
por: Xu, Shengchao, et al.
Publicado: (2021)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Survival analysis of immune-related lncRNA in low-grade glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma
por: Zhao, Jingwei, et al.
Publicado: (2020)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs
por: Wen, Jing, et al.
Publicado: (2020)

Foreboding lncRNA markers of low-grade gliomas dependent on metabolism
por: Lu, Zhuangzhuang, et al.
Publicado: (2022)

Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
por: Zhang, Qiang, et al.
Publicado: (2021)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Prognostic potential of lncRNA RHPN1-AS1 in glioma
por: Wu, Yong, et al.
Publicado: (2020)

The prognostic value and mechanisms of lncRNA UCA1 in human cancer
por: Yao, Fei, et al.
Publicado: (2019)

LncRNA SBF2-AS1 Promotes Diffuse Large B-Cell Lymphoma Growth by Regulating FGFR2 via Sponging miR-494-3p
por: Fu, Dong-Wei, et al.
Publicado: (2021)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Prognostic value of immune-related lncRNA pairs in patients with bladder cancer
por: Gao, Zhenzhen, et al.
Publicado: (2021)

Immune-Related lncRNA Correlated with Transcription Factors Provide Strong Prognostic Prediction in Gliomas
por: Tian, Yixin, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
por: Xia, Wenfei, et al.
Publicado: (2020)

LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p
por: Wang, Yi, et al.
Publicado: (2022)

Prognostic and Predictive Value of a Long Non-coding RNA Signature in Glioma: A lncRNA Expression Analysis
por: Pan, Yuan-Bo, et al.
Publicado: (2020)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

The prognostic value of lncRNA SNHG6 in cancer patients
por: Shen, Haixiang, et al.
Publicado: (2020)

Correction to: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1
por: Xia, Wenfei, et al.
Publicado: (2020)

A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
por: Zhong, Jiasheng, et al.
Publicado: (2022)

LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma
por: Shi, Fei, et al.
Publicado: (2023)

Developing a lncRNA Signature to Predict the Radiotherapy Response of Lower-Grade Gliomas Using Co-expression and ceRNA Network Analysis
por: Li, Zhongyang, et al.
Publicado: (2021)

Retracted: LncRNA SBF2-AS1 Facilitates Nonsmall Cell Lung Cancer Progression by Targeting miR-520a-3p
por: Healthcare Engineering, Journal of
Publicado: (2023)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration
por: Shi, Zhenyi, et al.
Publicado: (2023)

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients
por: Wang, Yangyang, et al.
Publicado: (2021)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Immune Subtypes Based on Immune-Related lncRNA: Differential Prognostic Mechanism of Pancreatic Cancer
por: Zhang, Qiyao, et al.
Publicado: (2021)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
por: Qiu, Huaide, et al.
Publicado: (2021)

An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_linn49bolt0f29d7nlmkgmrv4t